Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
EBIT Growth

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 18.2869.62-19.54-53.8883.25

What is the latest EBIT Growth ratio of AUROBINDO PHARMA ?

The latest EBIT Growth ratio of AUROBINDO PHARMA is 18.28 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202518.28
Mar202469.62
Mar2023-19.54
Mar2022-53.88
Mar202183.25

How is EBIT Growth of AUROBINDO PHARMA Trending?

Years EBIT Growth % Change
Mar2025 18.28
-73.74
Mar2024 69.62
Positive
Mar2023 -19.54
Negative
Mar2022 -53.88
Negative
Mar2021 83.25 -

Other Financial Ratios of AUROBINDO PHARMA


Compare EBIT Growth ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹60,998.5 Cr -3.7% -6% -31.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,187.0 Cr 0.6% -2.4% -7% Stock Analytics
DIVIS LABORATORIES ₹163,282.0 Cr -0.3% -7.6% 23% Stock Analytics
CIPLA ₹128,619.0 Cr 1.8% 8.1% -0.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹124,712.0 Cr 0.9% 3.7% 8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,577.0 Cr 1% 2.4% -9.6% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-3.7%

-6%

-31.1%

SENSEX

0.9%

-1.1%

0.6%


You may also like the below Video Courses